Download April 2011

CHINESE MEDICINAL BIOTECHNOLOGY
Bimonthly
Established in December 2006
Responsible Institution
Ministry of Health of the People’s
Republic of China
Sponsor
China Medicinal Biotech Association
7B Zaojunmiao Road, Haidian District,
Beijing 100081, China
Editing
Editorial Board of Chinese
Medicinal Biotechnology
Institute of Medicinal Biotechnology,
Chinese Academy of Medical Sciences
1#, Tian Tan Xi Li, Beijing, 100050, China
Email: [email protected]
http://www.cmbp.net.cn
Editor-in-Chief
ZHAO Kai（赵铠）
Managing Director
SHENG Feng-nian（盛丰年）
Publishing
Publishing House,
Chinese Medicinal Biotechnology
7B Zaojunmiao Road, Haidian District,
Beijing 100081, China
Tel: 0086-10-62135779
Fax: 0086-10-62115976
Email: [email protected]
Printing
Beijing Zhongke Printing Limited
Company
Overseas Distributor
China International Book
Trading Corporation
P. O. Box 399, Beijing, China
Code No. BM4275
Mail-Order
Publishing House,
Chinese Medicinal Biotechnology
7B Zaojunmiao Road, Haidian District,
Beijing 100081, China
Tel: 0086-10-62135779
Fax: 0086-10-62115976
Email: [email protected]
Volume 6, Number 2
April 10, 2011
CONTENTS OF SELECTED ARTICLES
Editorial
Advances in microbial drug research and development …………………… 81
SI Shu-yi, JIANG Wei, BAI Shuo-ke
Original Articles
Expression and the physical and chemical characterizations studies
of two recombinant human serum albumin/interferon-α (2a; 2b)
fusion proteins with long-acting bio-function ……………………………… 84
FU Yan, HAN Guo, YANG Xiao-nan, FU Yu-song, XING Jing,
HU Jun-xia, CHEN Ying, YUN Wen-qi, YU Zai-lin
Observation of viability and BMP-2 secretion of three different
microcapsulated adult stem cells transfected with BMP-2 gene ……… 96
SHEN Yang, ZHANG Shu-hong, TANG Ting-ting
Carboxyamidotriazole and low dose dexamethasone significantly
inhibit the growth of A549 xenograft tumors …………………………… 101
JU Rui, WU Dan-wei, GUO Lei, LI Juan, YE Cai-ying, ZHANG De-chang
Effects of the combination of anti-human DR5 monoclonal antibody
and 5-Fluorouracil on the proliferation
of colorectal cancer cells in vitro …………………………………………… 106
GAO Xu, ZHOU Zheng, SHEN En-yun, JING Xiao-juan, GUO Lei-ming,
WANG Xian-bin, SUN Jin-wen, DU Yun-feng
Effect of Yuchangning capsule releasing drug respectively in stomach
and colon on ulcerative colitis in rats caused by TNBS ………………… 111
XIE Xing-liang, SHENG Yan-mei, HAN Li, YANG Ming
Isolation, structure identification and anti-tumor activity of
potential small-molecular inhibitor of human Aurora-B kinase
from microbial nature products ……………………………………………… 116
NIU Yu-qiang, JIANG Wei, YU Li-yan, WANG Yan-chang, LI Yan, SI Shu-yi
The construction and transformation of Ginseng SQE gene
interference vector …………………………………………………………… 121
YU Yan-ting, REN Li, SUN Chun-yu, JIANG Shi-cui, WANG Yi, ZHANG Mei-ping
Reviews
Insights into the mechanisms of molecular therapy for heart failure …… 127
XIONG Qin-mei, HONG Kui
Advances in clinical research of new drug
for hepatocellular carcinoma ………………………………………………… 131
JIA Jin-bin, NI Shu-xin
CSSN
ISSN 1673-713X
CN 11- 5512 / R
Research progress on biofilm formation and detection
of coagulase-negative Staphylococcus …………………………………… 134
Copyright© 2011 by the Publishing
House, Chinese Medicinal
Biotechnology
Research progress on new dosage forms of resveratrol …………………… 138
All articles published represent the
opinions of the authors, not reflecting
the official policy of the China
Medicinal Biotech Association or the
Editorial Board of Chinese Medicinal
Biotechnology, unless this is clearly
specified.
Technology and Method
Production of crocin by the bubble column bioreactor …………………… 141
JIANG Mei-juan, WANG Hua-qiang, WANG Dan-dan, LIANG Bing
LI Wan-zhong, TIAN Jing-zhen
CHEN Shu-an, WANG Xiao-dong, YUAN Xiao-fan, ZHAO Bing, WANG Yu-chun
Study on accelerated release testing method
of dutasteride PLGA microspheres ………………………………………… 145
WANG Kai-yuan, GAO Yong-liang